Table 3.
Topographical CC Analysis (Ring = 500 µm): Data and Comparisons (T1 vs T2)
DM Group | Non-DM Group | |||||
---|---|---|---|---|---|---|
T1 | T2 | P Value | T1 | T2 | P Value | |
CC FD% | 54.61 [51.18–59.79] | 54.04 [49.71–60.12] | 0.897 | 51.51 [41.14–58.07] | 47.09 [40.15–54.41] | 0.003 |
CC FDa | 108.28 [78.75– 176.76] | 92.64 [67.58–150.52] | 0.247 | 78.05 [41.59–119.81] | 67.92 [35.41–87.27] | 0.008 |
CC FDn | 261.0 [172.9–492] | 288.8 [199.0–419.7] | 0.983 | 536.0 [319.8–890.8] | 738.0 [382.0–1000] | 0.003 |
Data are presented as median [IQR].
FDa, FD average area; FDn, flow deficits number; T1, before loading anti-VEGF therapy; T2, after loading anti-VEGF therapy.